Special Attention to Physical Activity in Breast Cancer Patients during the First Wave of COVID-19 Pandemic in Italy: The DianaWeb Cohort.

COVID-19 pandemic DianaWeb breast cancer epidemiology health management physical activity

Journal

Journal of personalized medicine
ISSN: 2075-4426
Titre abrégé: J Pers Med
Pays: Switzerland
ID NLM: 101602269

Informations de publication

Date de publication:
06 May 2021
Historique:
received: 11 04 2021
revised: 30 04 2021
accepted: 04 05 2021
entrez: 2 6 2021
pubmed: 3 6 2021
medline: 3 6 2021
Statut: epublish

Résumé

Recent evidence highlights that physical activity (PA) is associated with decreased recurrence risk, improved survival and quality of life for breast cancer (BC) patients. Our study aimed to explore patterns of increased/decreased PA, and sedentary behaviors among BC women of the DianaWeb cohort during the first wave of COVID-19 pandemic, and examined the association with residential locations, work changes, different modality used to increase PA, and quality of life. The study analyzed the questionnaires completed by the 781 BC women (age 54.68 ± 8.75 years on both December 2019 and June 2020. Results showed a decrease of 22%, 57%, and 26% for walking activity, vigorous activity, and total PA, respectively. Sitting/lying time increased up to 54.2% of the subjects recruited. High quality of life was associated with lower odds of being sedentary (

Identifiants

pubmed: 34066580
pii: jpm11050381
doi: 10.3390/jpm11050381
pmc: PMC8148515
pii:
doi:

Types de publication

Journal Article

Langues

eng

Références

Med Sci Sports Exerc. 2019 Nov;51(11):2375-2390
pubmed: 31626055
BMJ Open. 2016 Jun 01;6(6):e009707
pubmed: 27251681
J Sport Health Sci. 2020 Mar;9(2):103-104
pubmed: 32099716
Epidemiol Rev. 2017 Jan 1;39(1):71-92
pubmed: 28453622
Lancet. 2012 Jul 21;380(9838):219-29
pubmed: 22818936
Curr Oncol. 2018 Apr;25(2):117-118
pubmed: 29719426
Eur J Sport Sci. 2020 Dec 6;:1-10
pubmed: 33108970
J Natl Cancer Inst. 1993 Mar 3;85(5):365-76
pubmed: 8433390
Breast. 2019 Apr;44:144-152
pubmed: 30780085
Int J Environ Res Public Health. 2020 Dec 15;17(24):
pubmed: 33334073
Clin Ter. 2020 Jan-Feb;170(1):e59-e65
pubmed: 31850486
J Transl Med. 2020 Jun 8;18(1):229
pubmed: 32513197
JCO Oncol Pract. 2020 Oct;16(10):656-664
pubmed: 32603253
Disabil Rehabil. 2013;35(24):2038-45
pubmed: 23772995
Curr Oncol. 2006 Aug;13(4):119-20
pubmed: 17576451
Breast Care (Basel). 2018 Apr;13(2):93-101
pubmed: 29887785
Nature. 2020 Apr;580(7802):176-177
pubmed: 32235922
ESMO Open. 2017 Dec 11;2(5):e000271
pubmed: 29259819
N C Med J. 2014 Jul-Aug;75(4):283-6
pubmed: 25046097
Med Sci Sports Exerc. 2003 Aug;35(8):1381-95
pubmed: 12900694
Br J Sports Med. 2016 Mar;50(6):372-8
pubmed: 26500336
Front Physiol. 2021 Feb 05;12:624169
pubmed: 33613314
Cancer Epidemiol Biomarkers Prev. 2017 Mar;26(3):355-365
pubmed: 27742668
PLoS One. 2019 Aug 1;14(8):e0220814
pubmed: 31369653
Epidemiol Prev. 2015 Sep-Dec;39(5-6):402-5
pubmed: 26554696
Eur J Sport Sci. 2021 Apr;21(4):614-635
pubmed: 32394816
BMC Cancer. 2016 Jan 05;16:4
pubmed: 26732757
Int J Behav Nutr Phys Act. 2011 Oct 21;8:115
pubmed: 22018588
Int J Environ Res Public Health. 2020 Sep 05;17(18):
pubmed: 32899495
Psychooncology. 2015 Oct;24(10):1279-1285
pubmed: 29978929
J Sport Health Sci. 2019 Sep;8(5):457-462
pubmed: 31534820

Auteurs

Valentina Natalucci (V)

Department of Biomolecular Sciences, University of Urbino Carlo Bo, 61029 Urbino, Italy.

Milena Villarini (M)

Department of Pharmaceutical Sciences, University of Perugia, 06122 Perugia, Italy.

Rita Emili (R)

U.O.C. Oncologia Medica, ASUR Area Vasta 1, Ospedale Santa Maria della Misericordia di Urbino, 61029 Urbino, Italy.

Mattia Acito (M)

Department of Pharmaceutical Sciences, University of Perugia, 06122 Perugia, Italy.

Luciana Vallorani (L)

Department of Biomolecular Sciences, University of Urbino Carlo Bo, 61029 Urbino, Italy.

Elena Barbieri (E)

Department of Biomolecular Sciences, University of Urbino Carlo Bo, 61029 Urbino, Italy.

Anna Villarini (A)

Department of Research, Epidemiology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, 20133 Milano, Italy.

Classifications MeSH